Navigation Links
The Sir Allen Stanford Pediatric Fellowship Program Provides Close To CHF 1 Million to Support Kinderspital Zurich
Date:6/12/2008

ZURICH, Switzerland, June 12 /PRNewswire/ -- Stanford Financial Group ("Stanford") announces the Sir Allen Stanford Pediatric Fellowship Program with Kinderspital Zurich - the University Children's Hospital in Zurich. Stanford's new program will provide financial support to Kinderspital Zurich for a fellowship scheme focused on pediatrics that is unique in Switzerland.

Starting in summer 2008 and running for 5 consecutive years, Stanford will fund three Fellowships each year, allowing these specialists to each spend a training year to deepen their knowledge in their respective fields. In addition to the Sir Allen Stanford Pediatric Fellowship Program, Stanford is funding additional brief study trips for individual doctors. The total amount of financial support provided by Stanford across both programs will amount to almost CHF 1 million over the 5 years.

Sir Allen Stanford has said, "I believe that nothing strengthens a community more than healthy, happy children. Nothing." Professor Hans Weder, President of the University of Zurich agrees and confirmed that "Generations of doctors will benefit directly or indirectly from the program and improve the well-being of countless children, young people and families. We are extremely grateful and excited about the opportunities that the Sir Allen Stanford Pediatric Fellowship Program presents."

Kinderspital Zurich is the largest clinic in Switzerland specializing in pediatric surgery and care and is one of the largest pediatric hospitals in Europe. Professor Felix Sennhauser M.D., Director University Children's Hospital, said "Through the Sir Allen Stanford Pediatric Program, Stanford has for the first time made it possible for us to directly select fellows on tenure track positions in academic pediatrics and pediatric surgery and to reinforce the hospital as an international center of excellence today and for the future."

The Sir Allen Stanford Pediatric Fellowship Program makes it possible for young clinicians and university doctors to undertake suitable residencies to help them progress in their chosen specialty. The level of research possible through this Stanford program will occur at a deeper and more significant level focused on specific pediatric issues. Patients will benefit from medical and surgical treatment at the highest standards of quality based on the latest scientific findings.
For 2008, the three Stanford fellowships will focus on

1. Prediction of neurodevelopment outcome in very preterm infants using

cerebral function monitoring. The results will enable physicians and

therapists to optimize care for preterm babies and to individualize

therapeutic options.

2. Developing an instrument to facilitate the identification and the

assessment of patients requiring pediatric palliative care, those

suffering from illnesses that have no cure. Such care is crucial to

improve their quality of life.

3. Applying tissue engineering techniques in order to grow bladder tissue

for functional replacement in children suffering mainly from

congenital bladder malformations.

The Stanford Financial Group has a long-standing commitment to giving back in the communities where its companies are active. "Our relationship with Kinderspital Zurich continues the Stanford tradition of supporting meaningful philanthropy in the communities we serve. I am proud of our commitment and look forward to the significant advances that the Sir Allen Stanford Pediatric Fellowship Program will support," said L. Jack Staley, President of Stanford Group (Suisse) AG, the Stanford company headquartered in Zurich.

About Stanford Group (Suisse) AG

Stanford Group (Suisse) AG, an independent asset management and investment advisory company, is headquartered in the heart of the financial district of Zurich and provides private wealth management services to high-net-worth clients.

About Stanford Financial Group

Stanford Financial Group is a privately held global network of independent, affiliated financial services companies led by Chairman Sir Allen Stanford. The first Stanford company was founded by his grandfather, Lodis B. Stanford in 1932. Stanford's core businesses are private wealth management and investment banking for institutions and emerging growth companies.

The Stanford Financial Group of companies provides private and institutional investors with global expertise in asset allocation strategies, investment advisory services, award-winning policy and equity research, international private banking and trust administration, commercial banking, investment banking, merchant banking, institutional sales and trading, real estate investment and insurance. Stanford has over $43 billion in assets under management or advisement. Stanford Financial has made it a priority to invest in the communities in which it operates across the globe through signature corporate philanthropy initiatives with nonprofit organizations such as St. Jude Children's Research Hospital and countless local and international charities that strengthen communities.

Securities products and services are offered in the United States by Stanford Group Company, member FINRA/SIPC. Stanford Financial Group is not a legal entity, but a registered trademark that encompasses the global network of independent, but affiliated, privately held and wholly owned entities. More information on the company can be found at http://www.stanfordfinancial.com

About the University Children's Hospital Zurich

The University Children's Hospital Zurich is the largest clinic in Switzerland specializing in pediatric surgery and caring for children and young people, and is one of the largest pediatric hospitals in Europe. Young patients are treated by doctors who are highly specialized in nearly all areas of pediatrics and pediatric surgery. The University Children's Hospital Zurich has a strong reputation at home and abroad, both as an outstanding clinic and as an acknowledged centre of expertise in selected areas of highly specialized pediatrics.

As a university hospital, it also conducts teaching and research. Medical students and junior doctors at all levels are trained as pediatricians or pediatric surgeons. Fundamental research and clinical knowledge is driven forward in specific areas and selected research teams. Scientific and ethical standards meet the highest international norms. Testimony to the quality of the hospital is provided by the numerous publications and the close cooperation with specialists from other clinics and centers in Switzerland and abroad.


'/>"/>
SOURCE Stanford Financial Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
2. Summer is for Sleeping? Exhausted Americans Challenged to Sleep-in on Longest Day of the Year
3. White Ribbon Alliance for Safe Motherhood Challenges World Economic Forum on Africa to Invest in Womens Health
4. Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide
5. Lyme Lies: Allen Steeres horrifying comments regarding Lyme disease in last weeks commencement address
6. Rochester Coalition and Mayo Clinic Challenge Railroads Contention That Hazmat Rail Shipments Pose no Risk
7. Myanmar Cyclone Survivors Face New Challenges
8. Employee Engagement & Retention: Benchmarking Metrics and Networking Opportunity to Help Solve Todays Workforce Challenges
9. FasterCures President Greg Simon Testifies to U.S. Senate HELP Committee on Cancer Challenges and Opportunities in the 21st Century
10. The Challenge Kicks off 2nd Year - Tops 2 Million Pounds Lost, Half a Million Gain Healthier Lives
11. Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: